Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liposomal Doxorubicin”

1,080 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,080 results

Large-scale testing (Phase 3)Ended earlyNCT02359162
What this trial is testing

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

Who this might be right for
Lymphoma, Extranodal NK-T-Cell
Sun Yat-sen University 50
Early research (Phase 1)Study completedNCT00004162
What this trial is testing

Liposomal Doxorubicin Plus Combination Chemotherapy in Treating Patients With AIDS-Associated Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Alabama at Birmingham 48
Early research (Phase 1)WithdrawnNCT03111069
What this trial is testing

Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children

Who this might be right for
Malignant Neoplasms of Mesothelial and Soft TissueRhabdomyosarcoma, PelvicRhabdomyosarcoma, Abdominal
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00844883
What this trial is testing

Study of Sorafenib and Transarterial Chemoembolization (TACE) to Treat Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatoma
Yale University 50
Early research (Phase 1)Looking for participantsNCT06815575
What this trial is testing

A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.

Who this might be right for
Solid TumoursAdvanced Solid Tumours
Racura Oncology Ltd 53
Not applicableEnded earlyNCT02147301
What this trial is testing

TACE Using Doxorubicin-eluting Beads for Patients With HCC and Marginal Hepatic Reserve

Who this might be right for
Hepatocellular CarcinomaChemoembolization
University of California, San Francisco 17
Testing effectiveness (Phase 2)Study completedNCT00077428
What this trial is testing

Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Salivary Gland CancerSalivary Gland Adenoid Cystic Carcinoma+4 more
National Cancer Institute (NCI) 37
Large-scale testing (Phase 3)Study completedNCT00002707
What this trial is testing

Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed

Who this might be right for
Breast Cancer
NSABP Foundation Inc 2,411
Testing effectiveness (Phase 2)Study completedNCT01240629
What this trial is testing

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Prostate CancerHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
University of Southern California 43
Testing effectiveness (Phase 2)UnknownNCT06176339
What this trial is testing

Assessing the Clinical Utility of Adding Pentoxifylline to Neoadjuvant Chemotherapy Protocols in Breast Cancer Patients"

Who this might be right for
Breast Cancer Female
Mansoura University 70
Early research (Phase 1)UnknownNCT05273944
What this trial is testing

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients

Who this might be right for
Breast CancerOvarian Cancer
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT01367028
What this trial is testing

A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer

Who this might be right for
Breast Cancer
Austrian Breast & Colorectal Cancer Study Group 100
Large-scale testing (Phase 3)Study completedNCT01354522
What this trial is testing

TAC Versus TCX as Adjuvant Treatment for High-risk Her2-Negative Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 204
Large-scale testing (Phase 3)Study completedNCT00083876
What this trial is testing

D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas 500
Large-scale testing (Phase 3)Study completedNCT00053768
What this trial is testing

Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
German High-Grade Non-Hodgkin's Lymphoma Study Group 392
Testing effectiveness (Phase 2)Looking for participantsNCT05257018
What this trial is testing

R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse

Who this might be right for
Diffuse Large B-cell Lymphoma
Fudan University 83
Testing effectiveness (Phase 2)Active Not RecruitingNCT05283720
What this trial is testing

Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma

Who this might be right for
Non-Hodgkin Lymphoma
Genmab 264
Not applicableActive Not RecruitingNCT04180579
What this trial is testing

Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

Who this might be right for
Breast CancerBreast Cancer Stage IBreast Cancer Stage II+1 more
Memorial Sloan Kettering Cancer Center 34
Large-scale testing (Phase 3)Not Yet RecruitingNCT07823491
What this trial is testing

Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall

Who this might be right for
Resectable LiposarcomaResectable Soft Tissue SarcomaResectable Undifferentiated Pleomorphic Sarcoma
Ohio State University Comprehensive Cancer Center 228
Large-scale testing (Phase 3)Active Not RecruitingNCT05578976
What this trial is testing

Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Genmab 900
Next Page